EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Advances in targeting myocardial fibrosis: integrating mechanisms and therapeutics

Zihui Xu, Yuyan Zhao

Frontiers in Cardiovascular Medicine · 04.03.2026 · 13

DOI: 10.3389/fcvm.2026.1769016 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 04.03.2026. Verfasst von Zihui Xu und 1 weiteren Autor:innen. Beteiligte Einrichtung: The First Affiliated Hospital of China Medical University, Shenyang, Liaoning, China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 96 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Myocardial fibrosis (MF) is a maladaptive pathological response of the heart to chronic injury. Accumulating evidence indicates that MF plays a central role in the development and progression of hypertensive heart disease, ischemic cardiomyopathy, diabetic cardiomyopathy, and heart failure, and is closely associated with an increased risk of arrhythmias and sudden cardiac death. In recent years, advances in experimental and analytical approaches have improved our understanding of the molecular mechanisms underlying MF and informed the development of potential therapeutic strategies. However, many existing pharmacological interventions exhibit limited target specificity, uncertain long-term efficacy, and incompletely defined mechanisms of action in humans. In this review, we summarize the major molecular pathways involved in myocardial fibrosis and discuss current and emerging therapeutic approaches, incorporating mechanistic insights from recent single-cell and spatial transcriptomic studies to better contextualize fibrotic signaling heterogeneity and translational challenges.

Schlagwörter

Stichwörter der Autor:innen

drug developmentfibroblast activationheart failuremyocardial fibrosistherapeutic targets

Autor:innen und Institutionen

  • The First Affiliated Hospital of China Medical University, Shenyang, Liaoning, China.

Zitieren

APA

Xu, Z., & Zhao, Y. (2026). Advances in targeting myocardial fibrosis: integrating mechanisms and therapeutics. Frontiers in Cardiovascular Medicine, 13. https://doi.org/10.3389/fcvm.2026.1769016

Vancouver

Xu Z, Zhao Y. Advances in targeting myocardial fibrosis: integrating mechanisms and therapeutics. Frontiers in Cardiovascular Medicine. 2026;13. doi:10.3389/fcvm.2026.1769016

BibTeX
@article{Xu2026,
  author = {Xu, Zihui and Zhao, Yuyan},
  title = {Advances in targeting myocardial fibrosis: integrating mechanisms and therapeutics},
  journal = {Frontiers in Cardiovascular Medicine},
  year = {2026},
  volume = {13},
  doi = {10.3389/fcvm.2026.1769016}
}
Kostenlos starten →